-+ 0.00%
-+ 0.00%
-+ 0.00%

PExA study shows antibody responses differ between upper and lower airways

PUBT·11/18/2026 09:38:36
Listen to the news
PExA study shows antibody responses differ between upper and lower airways
  • PExA filed a European patent application on August 21, 2026, covering methods to measure and monitor immune responses in lower airways.
  • Supporting research results were already published in eBioMedicine, part of The Lancet Discovery Science.
  • The study found antibody responses can differ between upper and lower airways.
  • The technology enables noninvasive monitoring of small-airway antibody responses over time, potentially supporting vaccine development and expanding the platform's commercial applications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PExA AB published the original content used to generate this news brief via Cision (Ref. ID: 202611180437BITN____UKPR__EN_20261118-BIT-0929-0) on November 18, 2026, and is solely responsible for the information contained therein.